Estimated risk of transfusion-transmitted viral infections in Spain.
about
An autoregressive integrated moving average model for short-term prediction of hepatitis C virus seropositivity among male volunteer blood donors in Karachi, PakistanResidual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010.Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus.Deactivation of human immunodeficiency virus type 1 in medium by copper oxide-containing filters.Seroprevalence of human immunodeficiency virus in north Indian blood donors using third and fourth generation Enzyme linked immunosorbent assay.Transfusion Transmitted Infections in Armed Forces: Prevalence and Trends.Trends in transfusion transmitted infections among replacement blood donors in karachi, pakistanHCV transmission in industrialized countries and resource-constrained areas.Hepatitis B transmission by cell and tissue allografts: how safe is safe enough?Incidence and Residual Risk of HIV, HBV and HCV Infections Among Blood Donors in Tehran.Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil.Multicenter evaluation of a semiautomated, standardized assay for detection of hepatitis B virus DNA in blood donations.Evaluation of two, commercial, multi-dye, nucleic acid amplification technology tests, for HBV/HCV/HIV-1/HIV-2 and B19V/HAV, for screening blood and plasma for further manufacture.Diversity and origin of hepatitis C virus infection among unpaid blood donors in the Netherlands.Estimates of risk of window-period transmission of blood-borne viral diseases in Quebec.Bayesian evaluation of the human immunodeficiency virus antibody screening strategy of duplicate enzyme-linked immunosorbent assay in Xuzhou Blood Center, China.Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations.Acute hepatitis B virus window-period blood donations detected by individual-donation nucleic acid testing: a report on the first two cases found and interdicted in Spain.Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.Application of a new enzyme-linked immunosorbent assay for detection of total hepatitis C virus core antigen in blood donors.Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis.HCV screening in blood donations using RT-PCR in mini-pool: the experience in Spain after routine use for 2 years.Costs associated with blood transfusions in Sweden--the societal cost of autologous, allogeneic and perioperative RBC transfusion.International application of the incidence rate/window period model.Value of retaining HBsAg donor screening where HBV NAT and anti-HBc donor screening apply
P2860
Q27488317-1B8000B0-C62F-4C2C-9D3E-A7D85B28566CQ34346207-DD8085DC-4DDF-4A56-A851-FA0C5302A7D4Q36078723-672B11C1-FF40-4E5B-9DF0-9DBDFA9F4A72Q36403550-09D4E1CA-3854-40D5-B74C-4227033EB93BQ36425078-FBFCEE91-D941-44B8-A794-FF72585DC5E1Q37133683-3280EA87-F0F3-41BA-8D58-1FEA87A89385Q37277759-C47E58BD-661D-4173-B3F7-0C975CEAAF58Q37426415-0A2D99E7-9B70-4B36-A944-BED057B4F740Q38147886-8C33C3C2-D051-4CA6-893E-317C8D69AE1FQ38223372-4F69E0CB-6187-421D-8D8F-7271D5C52325Q40077221-99DFC0F1-850A-4A9A-B359-A9EA760B5B44Q40169707-398C585B-2944-47BF-87D7-63A50DF964B6Q42863755-6F559F52-DB6D-40F7-AC8E-6C848A6603FFQ42987407-35FAED3E-84B2-428B-A9EE-E5B08A8B6DADQ43031727-3DCF27F3-AB05-4FAE-B619-EDC44E6D0D5EQ43042563-2DAFA806-9B54-4A7A-A1D0-3C08E2D0FCB6Q45372714-E6D7A77A-30A6-4323-9EB0-76AC69C6D6E8Q45409042-598A8F70-0541-4658-BF40-3B7ED68EEF35Q45414662-A2A2789D-DF95-4AF8-AE16-5A3BAC58F844Q45423755-A2FAE72E-F7EF-4D78-942D-7F2A436343D7Q45709781-3AAAC833-3329-4D0E-895E-4A2F54A497A6Q46854672-58D98790-195C-45D3-A518-9F6946350C55Q47899782-8D767517-590A-421C-8C82-EAB820A194B9Q50758168-EB426F69-46B8-406B-8D21-5167A14FE091Q53307878-0CF367D5-E802-4D38-AD97-F64110CEAF6EQ57176158-DBECBC28-F0B9-4580-BAFD-17022F0FE0B3
P2860
Estimated risk of transfusion-transmitted viral infections in Spain.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Estimated risk of transfusion-transmitted viral infections in Spain.
@en
type
label
Estimated risk of transfusion-transmitted viral infections in Spain.
@en
prefLabel
Estimated risk of transfusion-transmitted viral infections in Spain.
@en
P2093
P2860
P1433
P1476
Estimated risk of transfusion-transmitted viral infections in Spain.
@en
P2093
J M Hernández
Manuel Alvarez
P M Rodríguez
Salvador Oyonarte
P2860
P304
P356
10.1046/J.1537-2995.2002.00154.X
P577
2002-08-01T00:00:00Z